These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12238630)

  • 1. Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model.
    Inoha S; Inamura T; Ikezaki K; Nakamizo A; Amano T; Fukui M
    Neurol Res; 2002 Sep; 24(6):607-12. PubMed ID: 12238630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
    Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
    Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model.
    Yamaguchi-Okada M; Nishizawa S; Mizutani A; Namba H
    Cerebrovasc Dis; 2009; 28(2):135-42. PubMed ID: 19506373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of the Expression and Activity of Phosphodiesterase V in the Basilar Artery Before and After Cerebral Vasospasm in a Rabbit Model.
    Huang D; Ju J; Jiang B; Wang Y; He W; Yin X; Guo W; Wang Z
    World Neurosurg; 2019 Dec; 132():e795-e801. PubMed ID: 31404697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study.
    Brenner S
    Neurology; 2006 May; 66(9):1455-6; author reply 1455-6. PubMed ID: 16682690
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage.
    Han BH; Vellimana AK; Zhou ML; Milner E; Zipfel GJ
    Neurosurgery; 2012 Jan; 70(1):178-86; discussion 186-7. PubMed ID: 21796010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
    Park K; Moreland RB; Goldstein I; Atala A; Traish A
    Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to the treatment of cerebral vasospasm: the angiographic effects of tadalafil on experimental vasospasm.
    Koktekir E; Erdem Y; Akif Bayar M; Gokcek C; Karatay M; Kilic C
    Acta Neurochir (Wien); 2010 Mar; 152(3):463-9. PubMed ID: 19841856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tetramethylpyrazine on nitric oxide/cGMP signaling after cerebral vasospasm in rabbits.
    Shao Z; Li J; Zhao Z; Gao C; Sun Z; Liu X
    Brain Res; 2010 Nov; 1361():67-75. PubMed ID: 20849833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
    Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
    Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions for therapy.
    Sobey CG
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):926-9. PubMed ID: 11703398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage.
    Washington CW; Derdeyn CP; Dhar R; Arias EJ; Chicoine MR; Cross DT; Dacey RG; Han BH; Moran CJ; Rich KM; Vellimana AK; Zipfel GJ
    J Neurosurg; 2016 Feb; 124(2):318-27. PubMed ID: 26314998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of inwardly rectifying potassium channels after experimental subarachnoid hemorrhage.
    Weyer GW; Jahromi BS; Aihara Y; Agbaje-Williams M; Nikitina E; Zhang ZD; Macdonald RL
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):382-91. PubMed ID: 16079788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the sildenafil citrate on cerebral vasospasm and apoptosis following experimental subarachnoid hemorrhage in rats.
    Gokce C; Gulsen S; Yilmaz C; Guven G; Caner H; Altinors N
    J Neurosurg Sci; 2010 Mar; 54(1):29-37. PubMed ID: 20436396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage.
    Zhou C; Yamaguchi M; Colohan AR; Zhang JH
    J Cereb Blood Flow Metab; 2005 May; 25(5):572-82. PubMed ID: 15729295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
    Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
    Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage.
    Zhou C; Yamaguchi M; Kusaka G; Schonholz C; Nanda A; Zhang JH
    J Cereb Blood Flow Metab; 2004 Apr; 24(4):419-31. PubMed ID: 15087711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of bovine type 5 phosphodiesterase confers a renal phenotype in Drosophila.
    Broderick KE; Kean L; Dow JA; Pyne NJ; Davies SA
    J Biol Chem; 2004 Feb; 279(9):8159-68. PubMed ID: 14662775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.